Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and Left Ventricular Hypertrophy

ezetimibe has been researched along with Left Ventricular Hypertrophy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cioffi, G; Cramariuc, D; Devereux, RB; Gerdts, E; Lønnebakken, MT; Pedersen, TR; Rogge, BP; Rossebø, AB1
Cramariuc, D; Gerdts, E; Rieck, AE; Tuseth, N; Wachtell, K1
Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lund, BP; Rieck, AE; Rossebø, AB1
Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Kesäniemi, YA; Køber, L; Nienaber, C; Ray, S; Rossebø, AB; Wachtell, K; Willenheimer, R1
Boman, K; Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lønnebakken, MT; Rieck, ÅE; Rossebø, AB; Staal, EM1

Trials

4 trial(s) available for ezetimibe and Left Ventricular Hypertrophy

ArticleYear
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
    Circulation. Cardiovascular imaging, 2015, Volume: 8, Issue:11

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Simvastatin

2015
Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
    The American journal of cardiology, 2010, May-15, Volume: 105, Issue:10

    Topics: Aged; Aged, 80 and over; Angiography; Aortic Valve Stenosis; Azetidines; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Ezetimibe; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Multivariate Analysis; Obesity; Probability; Prognosis; Risk Assessment; Severity of Illness Index; Simvastatin; Stroke Volume; Systole; Treatment Outcome

2010
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Circulation, 2012, Jan-17, Volume: 125, Issue:2

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Cardiovascular Diseases; Drug Therapy, Combination; Electrocardiography; Ezetimibe; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Simvastatin; Ventricular Dysfunction, Left

2012
Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:1

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Aortic Valve Stenosis; Azetidines; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Simvastatin

2012

Other Studies

1 other study(ies) available for ezetimibe and Left Ventricular Hypertrophy

ArticleYear
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
    Blood pressure, 2010, Volume: 19, Issue:3

    Topics: Aortic Valve Stenosis; Azetidines; Biomarkers; Cardiomegaly; Cardiomyopathy, Hypertrophic; Ezetimibe; Female; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Simvastatin

2010